Delivery Order SPE2DB20D3101-SPE2DB22FK6G3
- Not listed
- This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ARANESP 25 MCG/0.42 ML SYRING 0.42ML, a pharmaceutical product, with a ceiling value of $2,316.72 and an ultimate completion date of April 9, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,991.20 fixed-price contract provides ARANESP 200 MCG/0.4 ML SYRINGE 0.4ML, a medical supply product. This delivery order is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,131.55, is a delivery order for the supply of ARANESP 25 MCG/0.42 ML SYRING 0.42ML, a specialty pharmaceutical product. The contract has an ultimate completion date of February 24, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) held by...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of ARANESP 500 MCG/1 ML SYRINGEML, a specialty medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The $8,692.69 firm fixed price delivery order is a part of a larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military treatment programs and...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ARANESP 60 MCG/0.3 ML SYRINGE 0.3ML, a pharmaceutical product, with a ceiling value of $2,474.19. The contract is a firm-fixed-price delivery order, without a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a larger Indefinite...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ARANESP 100 MCG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with a ceiling value of $1,971.64 and a performance period ending on July 3, 2025. The contract is a firm fixed-price delivery order and is not set aside for any particular business type. AmerisourceBergen Drug Corp...
- This is a $5,863.99 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of ARANESP 40 MCG/0.4 ML SYRINGE 0.4ML, a medical product used for treatment. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of ARANESP 100 MCG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with a ceiling value of $1,971.64 and a period of performance through July 18, 2025. The contract is a firm fixed price, delivery order type, and is not a set-aside. Amerisourcebergen Drug Corp is a for-profit organization...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ARANESP 500 MCG/1 ML SYRINGEML, a specialty pharmaceutical product, with a ceiling value of $10,521.48. The contract is a firm fixed price contract with a period of performance through March 6, 2025. This contract was not designated as a set-aside and was awarded through open...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ARANESP 500 MCG/1 ML SYRINGEML, a medication, with a ceiling value of $12,222.04 and a performance period through May 8, 2025. The contract is a firm fixed-price, non-set-aside vehicle, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB22FK6G3Delivery Order
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of ARANESP 100 MCG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with a ceiling value of $22,229.22. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, which covers similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.2k | 8/12/22 |